[Therapy of mild to medium degree depression].
D000873:Anthracenes; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001643:Bridged Bicyclo Compounds; D003863:Depression / Q000503:physiopathology / Q000628:therapy*; D003866:Depressive Disorder / Q000145:classification* / Q000628:therapy; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010569:Perylene / Q000031:analogs & derivatives; D010696:Phloroglucinol / Q000031:analogs & derivatives; D010936:Plant Extracts / Q000627:therapeutic use; D010938:Plant Oils / Q000627:therapeutic use; D012720:Severity of Illness Index; D013729:Terpenes
D000873:Anthracenes; D000928:Antidepressive Agents; D001643:Bridged Bicyclo Compounds; D008996:Monoamine Oxidase Inhibitors; D010936:Plant Extracts; D010938:Plant Oils; D013729:Terpenes; D010569:Perylene; C004965:hypericin; D010696:Phloroglucinol; C001654:hyperforin
Therapie der milden bis mittelschweren Depression.